Participants interested in presenting their research at the Symposium are invited to submit their abstracts via the online submission system :Abstract submission
|Abstract Submission Deadline||Monday, October 30 2023 - midnight (GMT-6)|
|Abstract Notifications||Monday, November 20 2023|
INMIS abstract submissions are now being accepted through October 30, 2023.
INMIS 2024 will bring global stakeholders together to share up-to-date information on key areas in maternal and neonatal immunization. This major symposium will provide the opportunity for stakeholders from the entire spectrum of vaccinology research – laboratory science and clinical trials through to implementation and social science of immunization programs - to share the latest progress on maternal and neonatal immunization. Abstracts that are accepted will be assigned to either oral podium or oral e-poster presentation.
Abstract submission, selection and presentation
- Abstracts describing maternal and neonatal immunization research and implementation will be evaluated according in the following themes:
- Pre-clinical: including vaccine development and laboratory science;
- Clinical: including methodology, epidemiology of vaccine preventable diseases, Phase I-IV clinical trials, prevention of disease transmission, vaccine safety, immunology and impact of the microbiome;
- Programmatic: including vaccine implementation, vaccine acceptance and hesitancy, ethics, economics, modelling, program evaluation, vaccine coverage, post-marketing surveillance, impact on disease.
- Abstracts must be submitted via the online abstract submission system accessible from this site.
- All submitted abstracts will be reviewed by the Scientific Committee and, if accepted, will be allocated to an oral podium or e-poster session.
- Abstracts must be original and must not have been published prior to the INMIS 2024 meeting.
- Abstracts are to be submitted in English, and should not exceed 300 words, excluding title and authors. Abstracts are to include introduction/background & aims, methods, results and conclusions. Figures and Tables do not count against word count.
- The presenting author must ensure that all co-authors have approved the abstract before submission.
- Deadline for abstract submission is Monday, October 30, 2023 (11:59 p.m. Costa Rica time, GMT-6).
- Notification of acceptance will be sent by November 20, 2023.
- Presenting authors must register by January 15, 2024.
- Please note that travel visa for entry into Costa Rica may be required to some attendees. Follow this link to check if you will need a visa. You may ask the Organizing Committee for a letter to request your visa either when submitting your abstract or when registering for the Symposium.
Disclosure of all financial relationships that the author(s) have with the manufacturer/supplier of any commercial products or services related to the work must be indicated on the abstract submission form. All abstracts will be reviewed via the same process irrespective of these disclosures.
- INMIS 2024, with assistance from the Bill & Melinda Gates Foundation and other sponsors, will provide funding for travel bursaries to presenting authors who reside and are conducting research in low and middle income countries (LMICs) as per the Worldbank status and some Latin-American & Caribbean countries.
- Travel bursaries will cover the registration fee, hotel accommodation and provide travel support from the home country to San José, Costa Rica.
- Candidates must apply at the time of submission of their abstract on the INMIS Abstract submission page.
- Applicants will be selected on the basis of the quality of the abstract and availability of funds.
- Notification of travel bursaries will be sent jointly with abstracts notification by November 20, 2023.